ArticleMolecular oncology2023

Extracellular LGALS3BP: a potential disease marker and actionable target for antibody-drug conjugate therapy in glioblastoma.

Beatrice Dufrusine et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.